Merck & Co., Inc. (MRK)
100.83
-1.44
(-1.41%)
USD |
NYSE |
Dec 04, 16:00
101.02
+0.19
(+0.19%)
After-Hours: 20:00
Merck Market Cap: 250.26B for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 183.15B |
| Biogen, Inc. | 26.70B |
| Regeneron Pharmaceuticals, Inc. | 75.96B |
| Cidara Therapeutics, Inc. | 6.929B |
| Moderna, Inc. | 9.962B |
Market Cap Related Metrics
| PE Ratio | 13.34 |
| PS Ratio | 3.976 |
| PEG Ratio | 0.2286 |
| Price to Book Value | 4.827 |
| Price to Free Cash Flow | 19.47 |
| Price | 100.83 |
| Earnings Yield | 7.50% |
| PEGY Ratio | 0.2169 |
| Operating PE Ratio | 9.992 |
| Normalized PE Ratio | 11.80 |